Comprehensive NCLEX-RN Review — Anatomy, Physiology, Pathophysiology, Pharmacology, and Nursing Management
The heart wall consists of three distinct layers:
The precordium is the part of the front of the chest wall that overlies the heart and epigastrium — the area auscultated during a cardiac exam.
The heart has four chambers: Right Atrium, Left Atrium, Right Ventricle, and Left Ventricle.
The cardiac cycle includes contraction (systole) and relaxation (diastole) and has three stages:
| Vessel | Origin / Termination | Type of Blood |
|---|---|---|
| Superior / Inferior Vena Cava | → Right Atrium | Deoxygenated |
| 4 Pulmonary Veins | Lungs → Left Atrium | Oxygenated |
| Pulmonary Artery | Right Ventricle → Lungs | Deoxygenated |
| Aorta | Left Ventricle → Body | Oxygenated |
| Valve | Type | Location | Sound |
|---|---|---|---|
| Mitral (Bicuspid) | AV Valve | Between L. Atrium and L. Ventricle | S₁ |
| Tricuspid | AV Valve | Between R. Atrium and R. Ventricle | S₁ |
| Aortic | Semilunar | Origin of Aorta | S₂ |
| Pulmonary (Pulmonic) | Semilunar | Origin of Pulmonary Artery | S₂ |
Chordae tendineae are cord-like tendons attached to the tricuspid and mitral valves that prevent eversion of the valves during ventricular systole. They attach to papillary muscles, which are projections of the myocardium.
| Structure | Function | Inherent Rate |
|---|---|---|
| SA Node (Sinoatrial) | Primary pacemaker; initiates impulse | 60–100 bpm |
| AV Node (Atrioventricular) | Delays impulse, allowing atrial contraction before ventricular | 40–60 bpm |
| Bundle of His | Divides into Right and Left Bundle Branches | — |
| Purkinje Fibers | Distribute impulse through ventricles | 20–40 bpm |
| Term | Definition | Normal Value |
|---|---|---|
| Preload (EDV) | Volume of blood in ventricles before contraction | — |
| Afterload | Resistance ventricles must overcome to eject blood | — |
| Stroke Volume | Difference between preload and afterload | ~70 mL |
| Ejection Fraction | SV / EDV — percentage of blood ejected | 55–70% |
| Cardiac Output | SV × HR | ~4,900 mL/min (4–8 L/min) |
| CVP | Central venous pressure (right atrial pressure) | 3–8 mmHg (4–12 cm H₂O) |
| PCWP | Pulmonary capillary wedge pressure (L. ventricular pressure) | 4–12 mmHg |
| PAP | Pulmonary artery pressure | < 20 mmHg |
Key symptoms to assess include: shortness of breath (SOB), cough, dizziness, syncope, palpitations, chest pain, dyspnea, orthopnea (dyspnea relieved by sitting up), paroxysmal nocturnal dyspnea (PND), edema, cyanosis, history of rheumatic fever, STDs (syphilis), obesity, high cholesterol, and hormonal contraceptive use (↑ DVT risk).
| Location | Intercostal Space | Sound Heard Best |
|---|---|---|
| Aortic Area | 2nd right intercostal space | S₂ (aortic closure) |
| Pulmonic Area | 2nd left intercostal space | S₂ (pulmonic closure) |
| Erb's Point | 3rd left intercostal space, sternal border | S₂ best heard here |
| Tricuspid Area | 4th–5th left intercostal space | Tricuspid valve sounds |
| Mitral Area | 5th left intercostal space, midclavicular line | Mitral valve sounds |
Peripheral pulses are graded on a scale of 0–4: 0 = absent; 1 = palpable; 2 = normal; 3 = full; 4 = full and bounding (↑ BP, ↑ stroke volume).
BNP (B-type Natriuretic Peptide): Elevated in left ventricular failure (normal < 100 pg/mL). ANP (Atrial Natriuretic Peptide): Elevated in right ventricular failure, can cause nocturia.
| Marker | Rises | Peaks | Returns to Normal | Normal Value |
|---|---|---|---|---|
| Troponin I | 3 hours | 18–24 hours | 7 days | < 0.5 ng/mL |
| Troponin T | 3 hours | 18–24 hours | 7 days | < 0.1 ng/mL |
| CK-MB | 4–6 hours | 18–24 hours | 48–72 hours | < 5% of total CPK |
| Myoglobin | 1 hour | 4–6 hours | 24–36 hours | Not normally present |
| LDH (LDH₁ > LDH₂) | 24 hours | 48–72 hours | 10–14 days | 140–280 IU/L |
| Lipid | Normal / Desired Value |
|---|---|
| Total Cholesterol | < 200 mg/dL |
| LDL (Low-Density Lipoprotein) | < 100 mg/dL (ideal) |
| HDL (High-Density Lipoprotein) | > 60 mg/dL (desired); < 40 mg/dL poor |
| Triglycerides | < 150 mg/dL |
| Electrolyte | Normal Range | Hypo- Effects | Hyper- Effects |
|---|---|---|---|
| Potassium (K⁺) | 3.5–5.2 mEq/L | Ventricular arrhythmias, flattened T wave, U wave, digoxin toxicity risk | Asystole, peaked T wave, small P wave |
| Calcium (Ca²⁺) | 8.5–11 mg/dL | Prolonged ST and QT interval | Shortened ST, AV block, brady/tachycardia |
| Magnesium (Mg²⁺) | 1.5–2.5 mEq/L | VT, VF, Torsades de Pointes, hypotension | Prolonged PRI, wide QRS |
Indications: Diagnostic — evaluate anatomical defects, blood flow, conduction disturbances, coronary artery blockages. Therapeutic — stent placement, PTCA, temporary pacemaker.
| Pre-Test Care | Post-Test Care |
|---|---|
| Informed consent | Check circulation distal to insertion site |
| Ask about iodine/shellfish allergy | Check peripheral pulses, color, sensation q15min × 4 hrs |
| Monitor renal function | Monitor for numbness/tingling |
| NPO 8–12 hours prior | Keep extremity straight 6–8 hrs |
| Height, weight, baseline VS, peripheral pulses | Strict bed rest 6–12 hrs |
| Withhold metformin 24–48 hrs before | Observe site for bleeding/hematoma |
| Inform patient: warmth, flushing, salty taste, palpitations during procedure | Increase fluid intake; monitor for dysrhythmias, cardiac tamponade |
| Device | Measures | Normal | Nursing Care |
|---|---|---|---|
| CVP | Right atrial pressure (preload) | 3–8 mmHg | Maintain phlebostatic axis at mid-axillary line; ↑CVP = hypervolemia/CHF; ↓CVP = hypovolemia |
| Swan-Ganz | PA pressure, PCWP (left-sided pressures) | PAP < 20; PCWP 4–12 | Sterile dressing q24h; balloon deflated except during PCWP reading; same position each reading |
On ECG graph paper, the X-axis (horizontal) represents time in seconds, and the Y-axis (vertical) represents voltage in mV.
Each small square = 0.04 sec. Each large square = 0.04 × 5 = 0.2 sec. Five large squares = 1 second.
| Wave / Interval | Represents | Normal Duration | Clinical Significance |
|---|---|---|---|
| P wave | Atrial depolarization | — | Absent in atrial fibrillation, atrial standstill |
| PR Interval (PRI) | Time from atria through AV node | 0.12–0.20 sec | Prolonged = 1st degree AV block; variable = Wenckebach |
| QRS Complex | Ventricular depolarization | < 0.12 sec | Wide = bundle branch block, ventricular rhythms |
| ST Segment | Complete ventricular depolarization | Isoelectric | Elevation = STEMI; Depression = ischemia |
| T wave | Ventricular repolarization | — | Inverted = ischemia; Peaked = hyperkalemia |
| QT Interval | Ventricular systole to end diastole | Men ≤ 0.42; Women ≤ 0.43 | Prolonged = risk for ventricular tachyarrhythmias |
| U wave | — | — | If present, indicates hypokalemia |
Patient walks on treadmill with increasing intensity while ECG, BP, and symptoms are monitored. Indications: diagnose CAD, evaluate exercise tolerance, assess treatment effectiveness. Contraindications: acute MI, unstable angina, uncontrolled HTN, severe aortic stenosis.
Definition: Narrowing of the coronary arteries with decreased blood supply to the myocardium, primarily caused by atherosclerosis.
Risk Factors: Family history, ↑lipoproteins, smoking, diabetes mellitus, hypertension, obesity, sedentary lifestyle, stress, competitive lifestyle.
Findings: Dyspnea, chest pain, palpitations, syncope, cough, excessive fatigue.
Diagnosis: ↑Serum lipids, cardiac catheterization reveals atherosclerotic lesions.
| Drug Class | Examples | Side Effects | Nursing Implications |
|---|---|---|---|
| Statins (HMG-CoA Reductase Inhibitors) | Atorvastatin, Fluvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin | GI upset, ↑liver enzymes, Rhabdomyolysis | Periodic LFTs; annual eye exam; NO grapefruit juice (↑risk of liver/renal failure) |
| Bile Acid Sequestrants | Cholestyramine, Colestipol | GI disturbances | Mix powder well with water/juice; give 1 hr after other meds |
| Fibrates | Gemfibrozil, Fenofibrate, Clofibrate | GI upset | Monitor LFTs |
| Other | Ezetimibe, Niacin, Fish Oil | Flushing (niacin) | Niacin: take with food to reduce flushing |
Definition: Transient paroxysmal chest pain due to insufficient blood flow to the myocardium resulting in myocardial ischemia.
| Type | Characteristics |
|---|---|
| Stable (Exertional) | Relieved by rest or nitroglycerin; predictable pattern |
| Unstable (Preinfarction) | May not be relieved by nitroglycerin; increasing frequency/severity; medical emergency |
| Variant (Prinzmetal's) | Caused by coronary artery vasospasm; may occur at rest |
| Intractable | Chronic, incapacitating, unresponsive to interventions |
| Feature | Angina | MI |
|---|---|---|
| Pain | Temporary, relieved by rest or NTG | Unrelieved by rest or NTG; requires morphine |
| Cardiac Enzymes | Normal | Elevated |
| ECG | ST depression or T wave inversion during pain | ST elevation (STEMI) or depression (NSTEMI), T inversion, abnormal Q wave |
Definition: Death of myocardial cells from inadequate oxygenation, characterized by localized necrosis with subsequent healing, scar formation, and fibrosis.
| Intervention | Purpose |
|---|---|
| Morphine | Relieves pain and anxiety; vasodilation → ↓preload, ↓afterload, ↓cardiac workload, ↓O₂ demand |
| Oxygen | 2–4 L/min to improve oxygenation |
| Nitrates | Vasodilation, ↓preload |
| Aspirin | Antiplatelet effect; reduces mortality |
Additional: Beta blockers (metoprolol), establish IV line, bed rest with semi-Fowler's, 12-lead ECG, monitor urinary output (min 30 mL/hr), hemodynamic monitoring.
| Agent | Side Effect | Antidote |
|---|---|---|
| tPA (Alteplase, Activase) | Bleeding | Amicar (aminocaproic acid) |
| Streptokinase | ||
| Urokinase |
Definition: The heart is unable to pump enough blood to meet the metabolic demands of the body.
| Feature | Left-Sided Failure | Right-Sided Failure |
|---|---|---|
| Causes | LV damage from MI, HTN, aortic valve disease, mitral stenosis | LV failure, RV infarction, pulmonary stenosis, PE, COPD/CF/PH (Cor Pulmonale) |
| Key Signs | Dyspnea, orthopnea, PND, rales/crackles, S₃, wheezing, cyanosis, pallor, decreased peripheral pulses, oliguria, pink frothy sputum | Anorexia, weight gain, dependent edema, hepatomegaly, cool extremities, JVD, positive hepatojugular reflex, nocturia |
| Hemodynamics | ↑PAP, ↑PCWP, ↑BNP (>100) | ↑CVP, ↑SGPT (ALT) |
| Pulse | Pulsus alternans (alternating strong/weak) | — |
| Ejection Fraction | Systolic HF: EF < 40% (reduced); Diastolic HF: EF normal (preserved) | — |
| Medication | Key Points |
|---|---|
| Digoxin | Therapeutic level 0.8–2.0 ng/mL. SE: N/V/D, bradycardia, lethargy, photophobia, diplopia, yellow-green halos. Hold if HR < 60 (adults) or > 100. Monitor K⁺; hold if K⁺ < 3.5. Antidote: Digibind |
| Diuretics | Furosemide (Lasix) — monitor K⁺, give in morning |
| Potassium Supplements | Given with loop diuretics to prevent hypokalemia |
| IABP (Intra-aortic balloon pump) | Balloon in descending thoracic aorta; inflates during diastole, deflates during systole; triggered by ECG; uses helium or CO₂ |
Causes: Left-sided heart failure, rapid IV fluid administration.
Findings: Pink frothy sputum, severe dyspnea, cough, tachycardia, pallor, wheezing, rales, diaphoresis, JVD, ↓pO₂, ↑pCO₂, ↑CVP.
Management: Morphine, diuretics, digoxin, aminophylline, nitroglycerin, nesiritide, phlebotomy (300–500 mL), high concentration O₂ (40–60%), CVP monitoring, semi-Fowler's or over-bed table, prepare for intubation.
Definition: Persistent elevation of systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg.
| Type | Characteristics |
|---|---|
| Primary (Essential) | Associated with aging, loss of elasticity of blood vessels. Risk: aging, family history, smoking, stress, obesity, ↑Na, African American males |
| Secondary | Associated with other disease conditions (renal, endocrine, etc.) |
| Benign | Moderate rise, gradual onset, prolonged course. Stage 1: 140–159/90–99; Stage 2: ≥160/≥100 |
| Malignant (Crisis) | >180/120 mmHg. Rapid onset, short course. Can cause stroke, encephalopathy, renal failure, MI. S/S: headache, blurred vision, altered LOC, dyspnea, cyanosis, seizures |
Occipital headache, visual disturbances, dizziness, chest pain, tinnitus, epistaxis, flushed face, polyuria, dyspnea.
Loss of vision, CVA (stroke), CHF, renal failure.
See Cardiac Medications section below for detailed antihypertensive drug classes.
| Disorder | Pathophysiology | Key Findings |
|---|---|---|
| Mitral Stenosis | Narrowed mitral valve opening → ↓blood flow from LA to LV → ↑LA pressure → pulmonary HTN | Dyspnea, fatigue, hemoptysis, atrial fibrillation, S₁ loud, opening snap |
| Mitral Regurgitation | Incomplete closure → blood flows back into LA during systole → LA enlargement | Dyspnea, fatigue, holosystolic murmur at apex |
| Aortic Stenosis | Narrowed aortic valve → ↑LV pressure → LV hypertrophy → ↓CO | Syncope, angina, dyspnea on exertion, systolic ejection murmur at right 2nd ICS |
| Aortic Regurgitation | Incomplete closure → blood flows back into LV during diastole → LV volume overload | Water-hammer pulse, wide pulse pressure, diastolic murmur at left 3rd ICS |
Management: Valve replacement (mechanical or bioprosthetic) or valvuloplasty. Patients with mechanical valves require lifelong anticoagulation (warfarin). Bioprosthetic (tissue) valves may not require long-term anticoagulation but have limited durability.
Definition: Inflammation of the endocardium, leading to deposit of fibrin and platelets on mitral and aortic valves causing stenosis and insufficiency.
Causative organisms: Beta-hemolytic streptococcus, Gonococcus, Staphylococcus aureus.
Risk factors: Open heart procedures, rheumatic heart disease, GU/OB-GYN procedures, dental procedures (3–6 months prior), invasive monitoring, IV drug use, prosthetic valves.
| Sign/Symptom | Description |
|---|---|
| Fever, chills | Most common presenting symptoms |
| Cough, dyspnea | Pulmonary congestion |
| Murmurs | New or changing heart murmur |
| Petechiae | Small red/purple spots on skin or mucous membranes |
| Splenomegaly | Enlarged spleen |
| Clubbing | Fingertip enlargement from chronic hypoxia |
| Janeway Lesions | Non-tender hemorrhagic lesions on palms/soles |
| Osler's Nodes | Reddish, tender lesions on pads of fingers/hands/toes |
| Splinter Hemorrhages | Linear hemorrhages under nails |
Management: Antibiotics based on culture, antipyretics, surgical valve replacement for damaged valves. Emphasize prophylactic antibiotics before invasive procedures.
Definition: Inflammation of the parietal and visceral pericardium.
Causes: Secondary to bacterial/viral/fungal infection, acute MI, radiation, neoplasms, uremia, medications (procainamide, hydralazine, doxorubicin), collagen diseases (SLE, RA).
Findings: Chest pain radiating to left shoulder/neck/back, aggravated by inspiration/coughing/swallowing, worse supine, relieved leaning forward, hemoptysis, tachycardia, fever, pericardial friction rub, cyanosis/pallor, paradoxical pulse, JVD, ↑WBC/ESR/SGOT, ECG: ST elevation on all leads.
Management: Pain management, antibiotics, corticosteroids/salicylates/indomethacin to reduce inflammation.
Procedure: An obstructed coronary artery is replaced with a graft — most frequently the saphenous vein, brachial artery, mammary artery, or synthetic/porcine grafts.
| Pre-Op Care | Post-Op Care |
|---|---|
| Teach deep breathing/coughing with splinting | Monitor respiratory status; encourage coughing, deep breathing |
| Explain equipment (hemodynamic monitoring, ET tube/ventilator, chest tube) | Hemodynamic monitoring; Monitor ECG for dysrhythmias |
| Administer anticoagulants as ordered | |
| Monitor fluid/electrolytes; hourly urine output (<30 mL/hr = report) | |
| Chest tube drainage: report >100–150 mL/hr or >500 mL/24 hrs | |
| Effective pain management | |
| Assess VS and SpO₂ before ambulation; D/C if BP drops 10–20 mmHg or HR ↑ >10 bpm |
Indications: 2nd or 3rd degree AV block, bundle branch block, acute MI with Mobitz II, symptomatic bradycardia, Adams-Stokes attack, sick sinus syndrome.
| Type | Description |
|---|---|
| Fixed Rate | Fires at preset rate regardless of patient's rhythm |
| Demand | Fires only when patient's HR drops below preset rate |
| Temporary - Transcutaneous | Non-invasive; 2 large electrode patches on chest and back |
| Temporary - Transvenous | Invasive; lead wire inserted via antecubital, femoral, jugular, or subclavian vein |
| Permanent | Generator implanted subcutaneously under clavicle; lithium battery lasts ~10 years; function checked q3 months |
Definition: Accumulation of blood/fluid in the pericardium preventing adequate ventricular filling, can lead to cardiogenic shock.
Beck's Triad (Classic Signs): Muffled/distant heart sounds, low arterial BP, distended neck veins.
Other findings: Chest pain, tachycardia, pericardial friction rub, paradoxical pulse, sudden cessation of chest drainage after CABG, elevated CVP, ↓Hgb/Hct.
Management: CVP monitoring, pericardiocentesis, prepare for return to OR.
| Drug | Action | Side Effects | Nursing Considerations |
|---|---|---|---|
| Digoxin | ↑Contractility, ↓HR | N/V/D, bradycardia, lethargy, photophobia, diplopia, yellow-green halos, arrhythmias | Hold if HR <60 (adults); check K⁺; hold if K⁺ <3.5; therapeutic level 0.8–2.0; antidote: Digibind |
| Class | Examples | Action | Side Effects | Nursing Implications |
|---|---|---|---|---|
| 1st Gen (Non-selective) | Propranolol, Nadolol, Labetalol, Pindolol, Timolol | Block β-receptors → ↓HR, ↓contractility, ↓BP | Bradycardia, CHF, bronchospasm, hypoglycemia, impotence, depression, fatigue | Contraindicated in asthma; monitor HR/BP before giving; do not stop abruptly (may exacerbate ischemia); mask signs of hypoglycemia |
| 2nd Gen (Cardioselective) | Metoprolol, Atenolol, Bisoprolol | |||
| Non-selective α/β | Carvedilol |
| Class | Examples | Action | Side Effects | Nursing Implications |
|---|---|---|---|---|
| ACE Inhibitors | Captopril, Enalapril, Lisinopril, Ramipril, Quinapril, Benazepril | Inhibit conversion of angiotensin I → angiotensin II → vasodilation, ↓aldosterone | Stomatitis, taste loss, tongue ulcers, dry cough, hyperkalemia, pancytopenia, renal damage, proteinuria, angioedema, teratogenic | Monthly urine protein + CBC; CI in renal insufficiency; avoid K⁺-sparing diuretics; monitor K⁺ |
| ARBs | Losartan, Valsartan, Candesartan, Telmisartan | Block angiotensin II at receptor sites → ↓vasoconstriction, ↓aldosterone | Similar to ACE-I but less cough | Same monitoring as ACE-I |
| Examples | Action | Side Effects | Nursing Implications |
|---|---|---|---|
| Nifedipine, Nicardipine, Amlodipine, Verapamil, Diltiazem | Block Ca²⁺ entry → ↓cardiac contractility, ↓HR, vasodilation, ↓BP | Dizziness, hypotension, bradycardia, palpitations, flushing, arrhythmias, diarrhea/constipation, gingival hyperplasia | CI in CHF; avoid with β-blockers; monitor for hypotension with S/L nifedipine |
| Class | Examples | Action | Side Effects | Nursing Implications |
|---|---|---|---|---|
| Loop Diuretics | Furosemide, Torsemide, Ethacrynic Acid, Bumetanide | Act on Loop of Henle; block Na⁺/water reabsorption | Hyponatremia, hypokalemia, dehydration | Give in AM; give K⁺ supplements; only choice for renal patients; not recommended in pregnancy |
| Thiazides | HCTZ, Chlorthalidone, Metolazone | Promote renal excretion of Na⁺, K⁺, water | Hypokalemia, hyperuricemia, hypercalcemia, hyperglycemia, sexual dysfunction | CI in sulfa allergy; CI in renal insufficiency |
| K⁺-Sparing | Spironolactone, Triamterene, Amiloride, Eplerenone | Block aldosterone; excrete Na⁺/water, retain K⁺ | Gynecomastia, menstrual irregularities, hirsutism, impotence | No K⁺ supplements; avoid salt substitutes; CI in renal insufficiency/hyperkalemia |
| Osmotic | Mannitol, Glycerin, Isosorbide | ↑Osmotic pressure of glomerular filtrate | Pulmonary edema, N/V, headache, hyponatremia, dehydration | Mainly for ↑ICP and ↑IOP |
| Drug | Route | Action | Nursing Considerations |
|---|---|---|---|
| Nitroglycerin | S/L, IV, topical (cream/patch) | Vasodilation → ↓preload, ↓afterload, ↓O₂ demand | Check BP before each dose; max 3 S/L doses 5 min apart; store in amber glass; avoid ED drugs (sildenafil, tadalafil, vardenafil) |
| Isosorbide Dinitrate (Isordil) | PO (long-acting) | Same as NTG | Also used for chronic angina prophylaxis |
| Topical NTG (Transderm-Nitro) | Patch/cream | Same as NTG | Apply to non-hairy chest; rotate sites; remove old before new; remove 12 hrs daily to prevent tolerance; do not massage |
| Drug | Mechanism | Monitoring | Antidote | Nursing |
|---|---|---|---|---|
| Unfractionated Heparin | Blocks prothrombin → thrombin | PTT (goal 1.5–2× normal) | Protamine Sulfate | IV via pump; SQ: 90° angle, 26–27G, don't aspirate, don't massage |
| LMWH (Enoxaparin, Dalteparin) | Factor Xa inhibition | Anti-Xa levels | Protamine (partial) | Given SQ; do not expel air bubble; rotate sites |
| Warfarin (Coumadin) | Blocks vitamin K-dependent clotting factors | PT/INR (INR 2–3 typical) | Vitamin K (Aquamephyton) | Avoid sudden ↑ in vitamin K-rich foods; bleeding precautions (soft toothbrush, no floss) |
| Aspirin | Antiplatelet (COX inhibition) | — | — | Give with food to reduce GI irritation |
| Clopidogrel (Plavix) | ADP receptor blocker | — | — | Often combined with aspirin for ACS |
| Other Antiplatelets | Prasugrel, Ticagrelor, Abciximab, Dipyridamole | Various mechanisms | — | Monitor for bleeding |
| Class | Examples | Use | Key Points |
|---|---|---|---|
| Class I (Na⁺ channel blockers) | Lidocaine, Procainamide, Quinidine | Ventricular arrhythmias | Lidocaine: IV push for PVCs/VT; monitor for CNS toxicity |
| Class II (β-blockers) | Propranolol, Metoprolol | SVT, rate control in AFib | — |
| Class III (K⁺ channel blockers) | Amiodarone, Sotalol | VT, VF, AFib | Amiodarone: can cause pulmonary fibrosis, thyroid dysfunction, corneal deposits |
| Class IV (Ca²⁺ channel blockers) | Verapamil, Diltiazem | SVT, AFib rate control | — |
| Feature | Defibrillation | Cardioversion |
|---|---|---|
| Purpose | Terminate VF/pulseless VT | Convert SVT, AFib, VT (with pulse) |
| Synchronized? | No (asynchronous) | Yes (synchronized to R wave) |
| Energy | 200J → 300J → 360J | 50–100J (lower) |
| Procedure | Emergency — no sedation | Elective — sedation given |
| Feature | Arterial Ulcer | Venous Ulcer |
|---|---|---|
| Cause | Smoking, arterial occlusive disorders, diabetes | Thrombophlebitis, varicose veins, edema |
| Pulses | Diminished | Normal (may be hard to palpate due to edema) |
| Capillary Refill | Prolonged | Normal |
| Pain | Claudication | No claudication |
| Appearance | Necrotic, black/blue | Non-healing, granulation tissue, brownish/leathery |
| Management | Femoral-popliteal bypass, amputation | Prolonged dressing, Unna boot, elastic stockings, elevation |
Risk factors: Obesity, CHF, MI, pregnancy, smoking, trauma, dehydration, OCPs, prolonged immobility, post-op.
Findings: Superficial — pain, tenderness, induration, redness along vein. DVT — swelling, tenderness, positive Homan's sign (pain on dorsiflexion), cyanosis, ↑WBC/ESR, ↑D-dimer.
Management: Anticoagulation (heparin → warfarin). Surgical: venous thrombectomy, IVC filter (umbrella-like device in IVC).
Discharge teaching: Avoid prolonged standing/sitting, crossing legs, smoking, prolonged flying. Perform dorsiflexion exercises. Maintain hydration. Swimming is good exercise.
Definition: Usually related to a detached venous thrombus from deep veins of leg, right heart, or pelvic area — often affects lower lobes of lungs due to higher blood flow.
Findings: Pleuritic chest pain, severe dyspnea, tachypnea, rales, apprehension, tachycardia, hemoptysis, ↑temperature, shock symptoms if severe, ↑V/Q ratio, ↑D-dimer.
Management: Anticoagulants, thrombolytics, narcotics for pain. Surgery: embolectomy.
| Defect | Type | Description | Key Features | Management |
|---|---|---|---|---|
| ASD | Acyanotic | Opening in atrial septum → L→R shunt | Systolic ejection murmur at upper left sternal border; dyspnea | Amplifier closure or surgical closure (2–4 yrs) |
| VSD | Acyanotic | Opening in ventricular septum — most common CHD | Holosystolic murmur at lower left sternal border; FTT, CHF, frequent infections | Surgical closure or PA banding |
| PDA | Acyanotic | Failure of ductus arteriosus to close | Machinery murmur; higher in preemies; can cause CHF | Indomethacin (in preemies); ligation; coil |
| Coarctation of Aorta | Acyanotic | Stenosis distal to left subclavian artery | ↑BP in arms, ↓BP in legs; warm upper body, cool lower body; ↑risk of stroke | Resection & anastomosis |
| Tetralogy of Fallot (TOF) | Cyanotic | 4 defects: VSD, pulmonary stenosis, overriding aorta, RV hypertrophy | TET spells (cyanotic spells); squatting; clubbing; polycythemia; harsh systolic murmur | Palliative: Blalock-Taussig shunt; Corrective: total repair; knee-chest for TET spells |
TET spells (acute hypoxic episodes): precipitated by crying, feeding, defecation. S/S: cyanosis, tachypnea, tachycardia, altered LOC, flaccidity → may progress to seizure, CVA, or death.
Management: Morphine, Propranolol, Prostaglandins, Oxygen, Knee-chest position. If found squatting — allow child to stay in that position.
Definition: Cross-reactivity disorder after Group A β-hemolytic strep infection (usually strep throat). Peak incidence in school-age children.
| Major Symptoms (Jones Criteria) | Minor Symptoms |
|---|---|
| Carditis (SOB, hepatomegaly, edema, valve damage) | Recent strep infection history |
| Polyarthritis (migratory joint inflammation) | ↑ESR |
| Sydenham's Chorea (purposeless involuntary movements) | ↑ASO titer |
| Subcutaneous nodules (firm, non-tender on bony prominences) | ↑CRP |
| Erythema Marginatum (transient, non-pruritic rash) |
To confirm RF: 2 major symptoms OR 1 major + 2 minor symptoms.
Management: Penicillin (monthly injection until age 20 or 5 yrs after attack, whichever is longer); erythromycin if allergic to penicillin. NSAIDs, steroids. Bed rest until labs normalize. With chorea: ↓stimulation, safety precautions, assist with feeding.
| Topic | Key Points | NCLEX Priority |
|---|---|---|
| Anatomy | 3 layers (peri-, myo-, endocardium); 4 chambers; 4 valves; conduction: SA → AV → Bundle → Purkinje | LV thickest; SA node 60–100; Know coronary artery supply |
| ECG | P = atrial depolarization; QRS = ventricular; T = repolarization. Normal sinus: rate 60–100, regular, P before QRS, PRI 0.12–0.20 | ST ↑ = injury; ST ↓ = ischemia; U wave = hypokalemia; Peaked T = hyperkalemia |
| MI | Crushing chest pain, unrelieved by NTG; ↑troponin, ↑CK-MB; MONA therapy | Time is muscle; Door-to-balloon <90 min |
| Angina | Stable (relieved by rest/NTG) vs. Unstable (↑risk, may not respond to NTG) | NTG: 3 doses 5 min apart; ED drugs + NTG = severe hypotension |
| Heart Failure | L-sided: lungs (rales, PND, dyspnea); R-sided: body (edema, JVD, hepatomegaly); Systolic: ↓EF; Diastolic: normal EF | Daily weight; hold digoxin if HR <60; Na restriction |
| HTN | ≥140/90; Primary (essential) vs. Secondary; Malignant >180/120 = emergency | Never stop abruptly; lifestyle + medications |
| Medications | Digoxin (toxicity: halos, bradycardia); β-blockers (CI in asthma); ACE-I (cough, monitor K⁺); Diuretics (give AM, monitor K⁺) | Know antidotes: Digibind (digoxin), Protamine (heparin), Vitamin K (warfarin) |
| Dysrhythmias | PVC: wide QRS, no P; VT: 150–250; VF: chaotic, shockable | Defib (unsynchronized) vs. Cardioversion (synchronized) |
| Cardiac Surgery | CABG: post-op monitor chest tube (>100 mL/hr = report), urine (<30 mL/hr = report) | Pacemaker: avoid MRI, airport scanners |
| Pediatric | VSD most common CHD; TOF (4 defects); TET spells → knee-chest; Rheumatic fever → Jones criteria | Prophylactic antibiotics for dental procedures |